$2+ Bn PD-1 Resistant Head and Neck Cancer Markets - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2022 and 2023-2028F
12 févr. 2024 04h14 HE
|
Research and Markets
Dublin, Feb. 12, 2024 (GLOBE NEWSWIRE) -- The "PD-1 Resistant Head and Neck Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
Global Oncolytic Virus Therapy Market Report 2023: Increase in Clinical Trials and Approval of New Virus Therapies Boosts Growth
11 mai 2023 07h33 HE
|
Research and Markets
Dublin, May 11, 2023 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Therapy Market Outlook to 2035" report has been added to ResearchAndMarkets.com's offering.The global oncolytic virus therapy...
Insights on the Intratumoral Cancer Therapy Global Market to 2027 - by Application, Technology Type, End-users and Region
12 avr. 2022 04h43 HE
|
Research and Markets
Dublin, April 12, 2022 (GLOBE NEWSWIRE) -- The "Global Intratumoral Cancer Therapy Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Company Analysis" report has been...
Worldwide Cancer Immunotherapy Industry to 2027 - Featuring Amgen, AstraZeneca and Bayer Among Others
07 avr. 2022 07h53 HE
|
Research and Markets
Dublin, April 07, 2022 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Global Head & Neck Cancers Epidemiology and Patient Flow Analysis Report 2020-2035
13 mai 2021 07h28 HE
|
Research and Markets
Dublin, May 13, 2021 (GLOBE NEWSWIRE) -- The "Global Head & Neck Cancers Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering. Global Head & Neck...
Head & Neck Cancers: Global Clinical Trials Pipeline Report 2020-2025
07 sept. 2020 07h28 HE
|
Research and Markets
Dublin, Sept. 07, 2020 (GLOBE NEWSWIRE) -- The "Global Head & Neck Cancers Clinical Trial Pipeline Highlights - 2020" report has been added to ResearchAndMarkets.com's offering. The report...